معرفی
Dr. Nicola Acevedo is a Research Fellow at Swinburne University of Technology's School of Health Sciences, with expertise in clinical neuroscience and neurostimulation therapies for psychiatric disorders. She holds a BSc (Hon) from Monash University and a PhD from Swinburne University. Her research focuses on obsessive-compulsive disorder (OCD) treatment innovations, including deep brain stimulation (DBS), psychedelic-assisted psychotherapy, and neuroethical considerations in neuromodulation. Dr. Acevedo also serves as Clinical Trial Coordinator and Director of BioAutism, advocating for accessible, patient-centered mental health interventions. She actively collaborates with organizations like the Australasian Brain Stimulation Society (ABSS).
Education:
- BSc (Hon), Monash University, Melbourne
- PhD, Swinburne University of Technology
- Graduate Certificate in Research Commercialisation & Innovation (GC-RESIM), Swinburne University
Research Interests:
- Neurostimulation techniques for OCD and psychiatric conditions
- Psychedelic therapies for severe mental health disorders
- Cognitive-affective mechanisms of neuromodulation
- Neuroethical implications of emerging treatments
- Patient-centered care models
Publications: Her work spans 18 peer-reviewed articles, emphasizing DBS efficacy, anatomical targeting, and patient-reported outcomes. Recent studies include identifying optimal DBS stimulation sites and developing frameworks for assessing DBS-induced phenomenological changes in OCD patients.
Lab/Affiliations: Leads clinical trials at Swinburne, coordinates multidisciplinary projects, and directs BioAutism to advance autism research and advocacy.
